Research that will be presented at the American Heart Association’s Resuscitation Science Symposium in Philadelphia this month suggests the National Institutes of Health invests far less money in cardiac arrest research than in research for other conditions, including diabetes, drug-use disorders and ischemic heart disease.

The threat of antibiotic-resistant infections are on the rise, with more than 2.8 million occurring in the U.S. each year and more than 35,000 deaths, according to the CDC.

Cleveland Clinic has received its largest gift ever, a $261 million distribution from the Lord Foundation of Ohio, the nonprofit academic medical center disclosed Nov. 13.

Receiving that initial lung cancer diagnosis is not the death sentence that it used to be for some Americans, with more surviving the disease than ever before. 

Young people who use cannabis—especially if they’re frequent users—could face an up to threefold increased risk of stroke compared to their peers, researchers have found.

The boost in efficiency for measuring such scarring could make it easier for clinicians to overcome the time-consuming process of quantifying late gadolinium enhancement (LGE)—a proven predictor of hypertrophic cardiomyopathy.

XACT Robotics, a radiology technology company with offices in the United States and Israel, raised $36 million in its latest financing round.

Hospitals are leaving billions on the table when it comes to the U.S. supply chain, according to a new study from Navigant that found unnecessary supply chain spending reached $25.7 billion a year.

A collaboration between physicists and cardiologists at the University of California San Diego has resulted in an AI tool that can predict heart failure patients’ life expectancy with 88% accuracy.

Ultromics, a U.K.-based healthcare technology company, has gained FDA clearance for its new AI-powered image analysis solution.